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Abstract. In the animals with endotoxin-induced endothelial dysfunction there were imbalance of 
contractile response of vessels  wall observes when carrying out functional tests, increase of 
coefficient of endothelial dysfunction, decrease in contractility of a myocardium, activation 
processes of peroxidation of lipids and decreased activity of antioxidant systems, level of stable 
metabolites of nitrogen oxide. On extent of decrease in corrective effects on indicators of 
functional activity of a vessel wall, contractility of a myocardium, oxidatic indicators and level of 
stable metabolites of nitrogen oxide are studied preparations settle down in the following 
sequence: L-norvalin and rozuvastatin (coefficient of endothelial dysfunction – 1,2±0,1) → L-
norvalin and simvastatin (coefficient of endothelial dysfunction – 1,5±0,1) → rozuvastatin 
(coefficient of endothelial dysfunction – 1,6±0,1) → L-norvalin (coefficient of endothelial 
dysfunction – 1,7±0,2) → symvastatin (coefficient of endothelial dysfunction – 2,0±0,2). 
Keywords: endotoxin-induced endothelial dysfunction, statins, L-norvalin. 
 
Introduction. Sepsis is the most serious 
complication of infectious process. The mortality 
from the sepsis makes not less than 22,2 to 100 000 
population and it depends on original resistance of an 
organism to the infection, age, sex accompanying 
pathology, system activity including a regulation of 
homeostasis from functional activity of 
endotheliocytes [1, 2, 3]. The endothelial dysfunction 
(ED) is an imbalance between the mediators 
providing an ideal current of all endothelial 
dependent workflow. The vascular endothelial is a 
place for realization of normal and pathological 
immune and biochemical reactions proceeding with 
participation of mediators of inflammatory reaction, 
nitrogen oxide and its metabolites, active radicals of 
oxygen, etc. at the endotoxin-induced endothelial 
dysfunction (EIED)  [4, 5, 6, 7, 8, 9, 10].   
Pharmacological correction EIED must be 
contained in drugs using directly or indirectly 
influencing on endothelial functions ,its 
permeabilities and regulatory properties connecting 
to it metabolic shifts [11, 12, 13]. It is taken using of 
statins which are possessed of expressed 
antiphlogistic action and also they can be used in 
clinical practice for the main indication connected 
with the damage of сholesterol metabolism and 
antioxidant of L-norvalin which must up the level of 
L-arginin and prevent the endogenous inhibiting of 
NO-synthase [14, 15, 15]. 
Research objective – an evaluation of 
endothelio-and cardioprotective effects of statins and 
L-norvalin on rats with the endotoxin-induced model 
of endothelial dysfunction. 
OWN RESEARCHES 
Object of research. The experiments were on 
healthy pubertal rats lines Wistar, weighing 180-250 
g. In experiences there were the animals who passed 
a quarantine regimen of a vivarium of Kursk state 
medical university and they didn’t have external 
symptoms of any diseases. For receiving statistically 
reliable results of group it was formed 18-20 animals, 
the researches were at the same times of the days, 
from 8 to 12 h, according to rules of laboratory 
practice of the Russian Federation (the order the 
Ministry of Health of Russian Federation No. 267 of 
19.06.2003). 
The Modeling EIED was carried out under 
anesthetic, with keeping of rules of an asepsis and 
antiseptics: shaved wool, subcutaneously entered 0,1 
ml of a fresh suspension of Staphylococcus aureus 
(the strain 603 which was taken from the museum of 
department of microbiology, virology and 
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immunology of  KSMU) into concentration 
10·109/ml. Daily carried out compression, pneumatic 
massage of the place of an injection within 10 
minutes [16, 17]. After carrying out functional 
assays, for the 7th days from modeling of EIED, 
under anesthetic it was carried out a thoracotomy and 
blood sampling of 5 ml from a right ventricle of the 
reduced heart. Removal of animals from experiment 
were carried out an overdosage of anesthetics. 
Design of research, dosage, ways and 
frequency rate of administration of drugs. All 
experimental animals were divided into some groups: 
the 1st group (15 rats) – intact; the 2nd group (18 
rats) – animals with EIED which didn't have the 
drugs; the 3rd group (19 rats) – animals with EIED 
which were received symvastatin in a dose of 0,5 
mg/kg per os; 4th group (20 rats) – animals with 
EIED which were reseived rozuvastatin in a dose of  
0,125 mg/kg per os; the 5th group (20 rats) – animals 
with EIED which were entered L-norvalin in a dose 
of 10 mg/kg per os; the 6th group (18 rats) – animals 
with EIED which were received a combination of L-
norvalin and symvastatin per os in the same dosages; 
the 7th group (20 rats) – animals with EIED were 
received a combination of L-norvalin and a 
rozuvastatin per os in above-mentioned dosages. 
Dosages, ways and frequency administration of 
drugs were based on results of researches in available 
literature and the experiments were made earlier in 
laboratories according to which at such way of 
introduction the designated medicines render the 
most effective endothelio- and cardioprotective 
action [18]. 
Degree evaluation of endothelium in rats with 
EIED. Development of endothelial dysfunction in 
experimental animals was estimated on the settlement 
coefficient of endothelial dysfunction (CED).  
Making an assessment of results of functional 
test on endothelial dependent vazodilatation (EDVD) 
was used the area of a rectangular triangle over a 
curve of recovery of the ABP in response to 
introduction AH in a dose of 40 mkg/kg. Making an 
assessment of results of endothelial independent 
vasodilatation (EIVD) with introduction of NP in a 
dose of 30 mkg/kg was also used the area of a 
rectangular triangle over a curve of recovery of the 
ABP. Larger legs in both triangles were indicators of 
time of recovery of the ABP in response to 
intravenous administration AH and NP respectively 
expressed in seconds. The area of the estimated 
triangles was expressed in conventional units 
(conventional unit). CED is the relation of the area of 
a triangle over a curve of recovery of the ABP in 
response to introduction of NP (SNP) to the area of a 
triangle over a curve of recovery of the ABP in 
response to introduction AH (SAH). CED = SNP/SAH. 
Research of contractility of a myocardium at 
rats in a narcosis on the controlled respiration on 
open heart. Research of contractility of a 
myocardium after modeling of pathology was 
conducted on the rats in a narcosis on the controlled 
respiration. The cavity of a left ventricle was probed 
with a needle through an apex of heart and with the 
help of the sensor and the device for invasive 
measurement of indicators of a hemodynamics of 
Biopac (USA) and the computer Asq Knowledge 
3.8.1 program were recorded cardiohemodynamics 
indicators (left ventricular pressure (LVP), the 
maximum rate of reduction (+dp/dtmax), the maximum 
rate of relaxation (-dp/dtmax), the heart rate (HR) and 
the intensity of functioning of structures (IFS) (work 
of rate’s heart and pressure developed by a left 
ventricle (mm of mercury. x beats/min) [21]. For an 
assessment functionality of a myocardium on animals 
carried out load assays in the presented sequence:the 
assay on an adrenoreactivity (intravenous single-step 
administration of solution of Adrenalinum 
hydrochloricum 1 • 10 mmol/l, at the rate of 0,1 ml 
on 100 g); a load resistance (crossclamping of the 
ascending aorta on 30 sec.); a 3-minute hypoxia with 
the subsequent reoxygination. 
Assessment of oxidatic indicators. Intensity of 
processes of peroxidation of lipids was estimated 
according to contents in  blood plasma of MDA and 
AGP. For an assessment of a condition of 
antioxidatic system was defined the activity of a 
catalase with using of ready commercial sets. The 
general anti-oxidizing activity (GAA), determined by 
the method based on extent of inhibition of oxidation 
of the twin-80 to GAA. Concentration of stable 
metabolites of nitrogen oxide (SMNO) was 
investigated by a spectrophotoscopycal  method with 
the help of Gris's reactant and detection of the formed 
products at a wavelength of 540 nanometers. 
Statistical processing of results of research. 
Reliability of the changes which are observed on the 
effect of the studied drugs was determined by 
methods of descriptive statistics with finding of 
average values (M), by errors of average (±m) and 
probability of the possible mistake (r) calculated with 
use of t-test for groups with various dispersion. 
Differences were estimated as reliable, at р =0,05. 
RESULTS OF RESEARCH 
The condition of function of a vascular 
endothelium and contractility of a myocardium in 
the conditions of experimental model an 
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endotoxin-induced endothelial dysfunction. 
Modeling of EIED authentically didn't exert impact 
on the SABP and DABP in comparison with intact 
animals. After introduction AH it was increasing the 
level of SABP and DABP and the normal level of 
CCR on the  rats with EIED. There were no 
exchanges on the same rats with EIED after injection 
of NP. Increasing the areas of recovery of the ABP in 
assays on EDVD and EIVD on rats with EIED led to 
rising of CED to 3,7±0,5 in comparison with intact 
animals (CED = 1,1±0,1). The main contribution to 
rising of CED was made reliable, more than by 2,5 
times, depression of the area of a triangle over a 
curve of recovery of the ABP in response to 
intravenous administration AH (table 1).  
Table 1 
Results of carrying out functional vascular assays  
on animals with EIED (M±m; n=10) 
Groups of 
animals  
Functional tests  
SABP, 
mm of 
mercury  
DABP, 
mm of 
mercury 
CCR, 
bits per 
minute 
S of vascular reaction till 
the carrying out EDVD 
with AH and EIVD with 
NP,  
conventional unit. 
CED,  
convention
al unit. 
Intact  
Initial 129,4±2,2 89,2± 1,1 380±4,3  
1,1±0,1 AH 78,6±4,5 38,7±2,8 362±7,1 1268,0±74,8 
NP 85,8±3,7 45,5±4,4 364±5,4 1375,3±93,7 
Rats with 
EIED 
Initial 117,6±2,3 85,0±2,1 401±8,6  
3,7±0,5* AH 88,3±2,8* 53,1±2,4* 382±4,2 489,3±75,5* 
NP 83,3±4,2 40,2±2,3 387±7,5 1535,6±117,3 
Note: * - at р =0,05 in comparison with intact animals 
 
The specified fact demonstrates the expressed 
change of endothelia dependent reaction on rats with 
EIED. The animals with EIED increasing the level of  
indicators of the maximum speeds of reduction and 
relaxation of a myocardium on intact rats (+dp/dtmax 
and - dp/dtmax), at the same time it didn't influence on 
the LVP,  CCR and IFS level were observed. 
Intravenous injection of solution of adrenaline 
hydrochloride in a dose of 0,1 ml/100 weight gram in 
group of animals with EIED was characterized by 
increase of pressure created by the left ventricle, 
high-speed parameters of the +dp/dtmax and - dp/dtmax 
and IFS. CCR was the same in the group of intact 
animals. During the first 5 seconds of compression of 
the ascending aorta on intact animals were observed a 
sharp increase of pressure developed by the left 
ventricle, high-speed indicators of contractility 
reaction of myocardium and IFS. In comparison with 
intact animals, the rats with EIED had an accelerate 
relaxation of a myocardium and CCR. LVP and 
+dp/dtmax didn't differ from control values and IFS 
raised (table 2).  
The second phase (25 min) was characterized by 
gradual weakening of the contractive answer.  In this 
period the level of systolic tension bradycardia in 
group of intact animals decreased and amplified 
(LVP decreased to 212,7±10,9, CCR by decreased 
from 284,9±21,7 beats/min to 306,8±36,1 beats/min). 
There were higher indicator  – dp/dtmax, CCR and IFS 
in experimental group (table 2). 
Modeling of the hypoxia was reached by 
switching off the medical ventilator in the conditions 
of an open thorax. By the end of the 5th minute it 
took place a reoxygenation decrease in indicators of a 
contractility of the myocardium. In control group of 
animals when carrying out the test with a 
reoxygenation increasing the level of LVP, but 
decreasing the level of CCR were observed. As a 
result, decrease of IFS took place. In experimental 
group of rats the pressure developed by the left 
ventricle, speed of reduction and IFS had appeared 
higher, than on intact rats (table 2). 
So, modeling of EIED the endotheliy causes 
negative effects in experimental animals not only on 
contractility function of a myocardium, but also on 
functional activity that is shown by increase of CED 
and decrease in reserves of functional activity of a 
myocardium at statement of the majority of tests. 
Besides modeling of EIED it can be used for studying 
endothelio- and cardioprotective effects of various 
groups of pharmacological preparations. 
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Table 2  
Change of functional activity of a myocardium of animals with EIED receiving statins or L-norvalin (M±m; n=10) 
 
Groups 
 of animals 
Indicators  
Units of measure 
1 2 3 4 5 
Intact EIED 
EIED +  
rosuvastatin 
EIED +  
symvastatin 
EIED + 
L-norvalin 
Without 
functional 
trials 
LVP mm of mercury 105,3±4,5 110,1±7,1 107,8±4,7 108,0±3,6 103,0±3,0 
+dp/dtmax mm of mercury per sec  6570,9±783,4 8838,9±340,7
*1
 6597,0±372,6*2 7154,3±850,9*2 6822,4±1041,4*2 
-dp/dtmax mm of mercury per sec  4142,1±452,6 5206,1±255,7
*1
 4065,5±320,1*2 5308,3±480,8*1 4768,2±497,0*2,4 
CCR hart bits per second 361,3±14,7 372,5±10,5 379,3±6,0 373,2±6,3 366,3±12,0 
IFS mm of mercury х hart bits per sec 38421,1±2849,6 40756,4±2279,9 40905±1970 40251±1341 37867±1956 
Test on 
adrenoreact
ivity  
LVP mm of mercury 201,5±9,4 240,3±8,7*1 212,3±5,9*2 215,2±7,7*2 214,9±7,7*2 
+dp/dtmax mm of mercury per sec  10997,8±777,6 13959,2±735,9
*1
 9674,9±372,0*2 12876,9±366,2*1,3 10094,6±783,4*2,4 
-dp/dtmax mm of mercury per sec  5697,1±650,8 7830,5±520,9
*1
 4854,3±185,3*1,2 7910,1±504,2*1,3 5497,7±554,7*2-4 
CCR hart bits per second 374,4±14,5 379,0±9,4 395,7±4,4 381,2±5,6 369,1±8,8 
IFS mm of mercury х hart bits per sec 76236,2±5813,7 91294,1±4546,3*1 84048±2686*2 82304±3877*2 79014±2326*2 
Test with 
compressio
n of aorta 5 
sec. 
LVP mm of mercury 233,2±9,9 220,2±6,5 218,7±5,5 263,1±5,5 233,8±5,6 
+dp/dtmax mm of mercury per sec  9227,3±459,3 9555,9±400,2 6541,7±549,9
*1,2
 10143,2±284,8*3 8589,1±657,2*1,2,4 
-dp/dtmax mm of mercury per sec  3674,7±207,5 4241,6±275,4
*1
 4028,2±289,3*1 4734,8±167,4*1,3 3485,9±260,6*2-4 
CCR hart bits per second 284,9±21,7 366,8±10,6*1 370,7±9,4*1 331,9±13,9*1-3 334,6±10,6*1-3 
IFS mm of mercury х hart bits per sec 65459,1±3968,0 80568,6±2804,2*1 80933±2470*1 87336±4119*1-3 78060±2536*1,4 
Test with 
compressio
n of aorta 
25 sec. 
LVP mm of mercury 212,7±10,9 179,4±3,9*1 196,3±5,2*2 228,1±5,8*2 216,6±5,9*2 
+dp/dtmax mm of mercury per sec  6826,7±458,6 5144,0±238,3
*1
 5360,5±487,2*1 7945,0±416,2*1-3 8285,2±649,9*1-3 
-dp/dtmax mm of mercury per sec  3210,5±261,5 3034,3±237,6 3762,2±244,2
*1,2
 4281,1±342,2*1-3 2728,4±135,2*3,4 
CCR hart bits per second 306,8±36,1 259,4±14,4*1 311,3±19,6*2 273,7±11,1*2 266,9±13,2*1,3,4 
IFS mm of mercury х hart bits per sec 63004,9±5858,3 46520,4±2687,8*1 60903±3863*2 62042±1943*2 57908±3645*2 
Reoxygenet
ion test 
LVP mm of mercury 194,9±9,5 228,5±10,2*1 219,3±10,5*1,2 243,7±9,1*1-3 220,4±6,3*1,4 
+dp/dtmax mm of mercury per sec  8488,0±698,1 12221,3±363,4
*1
 9836,6±338,9*1,2 10965,6±946,3*1,2 8874,7±624,8*2-4 
-dp/dtmax mm of mercury per sec  4490,0±320,7 4692,5±219,5 4495,8±653,4 7039,6±495,4
*1-3
 4755,3±510,9*4 
CCR hart bits per second 252,3±19,3 269,6±14,9 296,4±20,4*1 231,4±13,4*2,3 240,6±15,6*2,3 
IFS mm of mercury х hart bits per sec 49670,1±4750,2 62068,7±5006,4*1 64769±5579*1 56293±3561*1-3 52626±2951*2-4 
 
Note: here and in the subsequent tables the asterisk has noted reliable differences of arithmetic averages at p = 0,05; figures near an asterisk indicate a column in 
relation to which this difference is reliable. Reductions: LVP – the left ventricular pressure, +dp/dtmax, - dp/dtmax - the maximum speeds of reduction and relaxation of a 
myocardium, CCR – the heart rate, IFS - intensity of functioning of structures. 
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Using of statins and L-norvalin in correction of 
violations of functions vascular an endotheliy and 
contractility function of a myocardium at animals 
with experimental model endotoxin-induced 
endothelial dysfunction. The animals with EIED 
receiving statins and L-norvalin, initial vascular 
reactions didn't differ from those group of the intact 
animals or rats who weren't received preparations. 
When carrying out test on EDVD with AH only in 
group of the animals receiving L-norvalin it was 
observed reliable in comparison with group of animals 
from EDED which weren't receiving preparations, 
decrease the SABP. When carrying out test from NP on 
EIVD contractility reactions of a vascular wall of rats 
from EIED receiving statins and L-norvalin were the 
same, as in groups with intact animals and when 
modeling EIED without introduction of preparations. 
The described changes of vascular reactions on the rats 
receiving rozuvastatin, symvastatin and L-norvalin 
(lack of the expressed increase the SABP and DABP at 
introduction AH), as a result, have led to increase, but 
not to the corresponding values in group of intact 
animals, the area of a triangle over a restoration curve 
ABP in test on EDVD. In turn, these changes, in 
comparison with model EIED became the reason of 
statistically essential decrease in CED: the introduction 
of a rozuvastatin – to 1,6±0,1, a symvastitine – to 
2,0±0,2 and L-norvalin – to 1,7±0,4 (table 3). 
 
Table 3 
Results of carrying out functional vascular tests on animals with EIED  
and its correction by means of a rozuvastatin, a symvastatin and L-norvalin (M±m; n=10) 
Groups of 
animals  
Functional 
tests  
SABP, 
mm of 
mercury  
DABP, 
mm of 
mercury 
CCR, 
bits per 
minute 
S of vascular 
reaction till the 
carrying out EDVD 
with AH and EIVD 
with NP, 
conventional unit. 
CED,  
conventiona
l unit. 
Intact  
Initial 129,4±2,2 89,2± 1,1 380±4,3  
1,1±0,1 AH 78,6±4,5 38,7±2,8 362±7,1 1268,0±74,8 
NP 85,8±3,7 45,5±4,4 364±5,4 1375,3±93,7 
Rats with EIED 
Initial 117,6±2,3 85,0±2,1 401±8,6  
3,7±0,5* AH 88,3±2,8* 53,1±2,4* 382±4,2 489,3±75,5* 
NP 83,3±4,2 40,2±2,3 387±7,5 1535,6±117,3 
Rats with EIED 
+ rozuvastatin 
Initial 129,8±2,9 89,1±2,6 372±12,3  
1,6±0,1** AH 85,0±1,9 46,3±2,0 365±12,8 864,3±60,4* 
NP 82,0±3,2 44,9±1,7 382±7,5 1375,8±112,2 
Rats with EIED 
+ symvastatin 
Initial 121,4±2,8 85,0±2,6 368±8,5  
2,0±0,2** AH 83,5±2,6 43,3±2,1 375±7,3 727,0±43,1* 
NP 75,3±3,0 43,8±2,2 399±10,2 1439,7±138,3 
Rats with EIED 
+ L-norvalin 
Initial 125,5±2,3 85,9±1,8 391±10,9  
1,7±0,4** AH 73,0±3,7** 45,5±1,4 379±11 836,8±72,7* 
NP 88,4±1,6 50,0±3,3 376±9,5 1286,0±150,4 
Note: * - at р =0,05 in comparison with intact animals; ** - at р =0,05 in comparison with the EIED model. 
 
The rats with EIED caused by introduction of 
staphylococcal endotoxin were observed statistically 
essential increase of high-speed parameters – 
+dp/dtmax and - dp/dtmax. Introduction of  rozuvastatin 
or L-norvalin normalized both broken indicator and 
symvastatin normalized +dp/dtmax, but it didn't exert 
impact on - dp/dtmax (table 2). 
When carrying out test on an adrenoreactivity on 
animals with EIED, receiving rozuvastatin, observed 
normalization of LVP, +dp/dtmax and IFS, but 
decrease - dp/dtmax. The group of the animals 
receiving sumvastatin was normalized LVP and IFS, 
however in comparison with the rats who weren't 
receiving preparations, changes of +dp/dtmax and - 
dp/dtmax didn't occur. The maximum corrective 
effects were observed in the group receiving L-
norvalin as all studied parameters of contractility 
function of a myocardium didn't differ from group of 
healthy animals (table 2). 
When carrying out test with compression of 
aorta on the 5th sec. on rats with EIED, receiving 
rozuvastatin, decrease observed +dp/dtmax, and 
indicators - dp/dtmax, CCR and IFS – remained raised. 
+dp/dtmax remained with the animals receiving 
sunvastatin at the normal level, but considerably 
raised - dp/dtmax, CCR and IFS. After introduction the 
experimental animals with EIED L-norvalin there 
were normalization of - dp/dtmax, decrease +dp/dtmax, 
but CCR and IFS were raised (table 2). 
On the 25th sec. at statement of test with 
compression of aorta in group of animals with EIED, 
receiving rozuvastatin, normalized LVP, CCR, IFS, 
raised - dp/dtmax and the reduced +dp/dtmax level didn't 
change. The rats receiving sumvastatin LVP, CCR and 
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IFS were normalized, but high-speed parameters of 
contractility function of a myocardium increased 
(+dp/dtmax and - dp/dtmax). Introduction of L-norvalin to 
rats with EIED caused normalization of LVP, IFS, 
increase of +dp/dtmax and decrease CCR (table 2). 
In test on a reoxygenetion at animals with EIED 
receiving rozuvastatin  decreased the level +dp/dtmax 
was observed, but CCR and IFS were raised. In group 
of the animals receiving symvastatin CCR was 
normalized, LVP, high-speed parameters of 
contractility function raised (+dp/dtmax and - 
dp/dtmax), it was exchanges of IFS, but not to 
indicators of the control group. Against application of 
L-norvalin for rats with EIED, observed the 
normalization of +dp/dtmax levels, - dp/dtmax, CCR 
and IFS which at the same time are slightly raised 
LVP (table 2). 
The rats with EIED were observed the rise of 
details in intermediate and final products of 
peroxidation of lipids (MDA, AGP) in blood plasma, 
decrease of the activity of a catalase, the general anti-
oxidizing activity (GAA) of blood plasma and 
concentration of SMNO   (figure 1). 
 
Designations: circle radius – indicators of intact animals;  
- indicators of rats with EIED; 
- indicators of rats with EIED, receiving symvastatin; 
- indicators of rats with EIED, receiving rozuvastatin;  
- indicators of rats with EIED, receiving L-norvalin; 
- normalized indicators. 
 
Figure 1. Change of oxidatic indicators and level of stable metabolites of nitrogen oxide at rats with EIED against application 
of statins and L-norvalin 
 
Introduction to rats with EIED of a simvastatin in a 
dose of 0,5 mg/kg reduced the maintenance of AGP, 
corrected activity of a catalase, the SMNO level, but it 
didn’t  control increase the level of MDA and decrease 
the level of GAA. The animals with EIED receiving 
rozuvastatin in a dose of 0,125 mg/kg, concentration of 
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SMNO was normalized, corrective effects were noted on 
indicators of products of peroxidation of lipids, activity 
of a catalase and GAA. Introduction of L-norvalin  in a 
dose of 10 mg/kg to rats with EIED corrected the level 
of MDA and AGP, but the most maximum level of 
SMNO and probably at the expense of its corrective 
effect of GAA  was distinctive feature of this 
connection (figure 1). 
By quantity the number of corrected indicators it is 
possible to claim that rozuvastatin and L-norvalin were 
slightly more effective than a simvastatin, however the 
last rendered corrective effects concerning separate 
indicators of vascular reactions and contractility 
function of a myocardium on which didn't render 
significant effects rozuvastatin and L-norvalin. In this 
regard it is possible to assume that combinations of 
statin and L-norvalin will possess bigger corrective 
efficiency of influence on the broken parameters. 
The combined application of statins and L-
norvalin in correction of violations of functional 
activity an endothelium and a myocardium on 
animals with endotoxin induced endothelial 
dysfunction. Combined using of L-norvalin and 
rozuvastatin on rats with EIED raised indicators the 
SABP and DABP in test on EDVD, and in group of 
the animals receiving a combination of L-norvalin 
and  simvastatin, there was an introduction of NP 
reliable decrease level of DABP in comparison with 
EIED rats. In calculation areas of the triangles over 
restoration curves of ABP in tests with AH and NP, 
in group of the animals receiving a combination of L-
norvalin and  rozuvastatin there was revealed 
statistically significant, in comparison with EIED 
group, increase in value of area of a triangle over  
restoration curve ABP in test with AH, close to that 
at intact animals and statistically significant decrease 
in this indicator at introduction of NP. The rats from 
EIED receiving a combination of L-norvalin and  
simvastatin, corrective changes were noted only 
concerning area of a triangle over a restoration curve 
ABP when carrying out test on EDVD, when 
carrying out test on EIVD area of a triangle over a 
restoration curve ABP didn't differ from that at intact 
animals or rats from EIED which weren't receive 
preparations. So, the combined application of L-
norvalin and statins has allowed to achieve more 
corrective effects on CED, in particular from the 
animals receiving L-norvalin and  simvastatin, CED 
decreased in comparison with the EIED model to 
1,5±0,1, and in the group receiving L-norvalin and 
rozuvastatin – to 1,2±0,1 (table 4). 
 
Table 4 
Results of carrying out functional vascular tests on animals with EIED  
and its correction by combinations of  rozuvastatin,  simvastatin  and L-norvalin (M±m; n=10) 
Groups of 
animals  
Functional 
tests  
SABP, 
mm of mercury  
DABP, 
mm of 
mercury 
CCR, 
bits per 
minute 
S of vascular reaction 
till the carrying out 
EDVD with AH and 
EIVD with NP,  
conventional unit. 
CED,  
conventiona
l unit. 
Intact  
Initial 129,4±2,2 89,2± 1,1 380±4,3  
1,1±0,1 AH 78,6±4,5 38,7±2,8 362±7,1 1268,0±74,8 
NP 85,8±3,7 45,5±4,4 364±5,4 1375,3±93,7 
Rats with EIED 
Initial 117,6±2,3 85,0±2,1 401±8,6  
3,7±0,5* AH 88,3±2,8* 53,1±2,4* 382±4,2 489,3±75,5* 
NP 83,3±4,2 40,2±2,3 387±7,5 1535,6±117,3 
Rats with EIED + 
rozuvastatin + L-
norvaliv 
Initial 118,1±2,3 75,6±4,5 400±7,1  
1,2±0,2** AH 78,4±2,5 36,6±1,6 390±6,8 1124,2±63,7** 
NP 101,1±4,1** 57,8±2,8** 362±5,8 1011,8±94,6** 
Rats with EIED + 
symvastatin + L-
norvalin 
Initial 128,1±2,1 83,1±2,6 376±7,1  
1,5±0,1** AH 83,2±3,4 40,3±2,7 380±6,8 1090,0±72,9** 
NP 80,4±2,9 35,9±1,9** 364±5,8 1563,6±135,2 
Note: * - at р =0,05 in comparison with intact animals; ** - at р =0,05 in comparison with the EIED model. 
 
Introduction of L-norvalin with rozuvastatin or 
simvastatin normalized +dp/dtmax and - dp/dtmax a 
myocardium of animals with EIED. However 
introduction of a combination L-norvalin and simvastatin 
raised CCR and IFS. When carrying out test on an 
adrenoreactivity on rats with EIED against application of 
combinations L-norvalin with rozuvastatin or simvastatin 
LVP, +dp/dtmax and IFS were normalized, decreased the 
level of - dp/dtmax (table 5). 
In test with compression of aorta on loading L-
norvalin with combination of rozuvastatin or 
simvastatin on the 5th sec. normalized - dp/dtmax, 
CCR, IFS, but it reduced the reduction speed. On the 
25th sec. of test version it was a normalization of all 
broken parameters of contractility function of 
myocardium animals with EIED (table 5). 
 Ivlitskaya I.L., Korokin M.V., Loktionov A.L. Pharmacological efficiency of statins and L-norvalin at an 
endotoxin-induced endothelial dysfunction. Research result: pharmacology and clinical 
pharmacology. 2016. Vol. 2, №2: 25-35. 
32 
 
RESEARCH RESULT:  
PHARMACOLOGY AND CLINICAL PHARMACOLOGY 
Table 5  
Correction of functional activity of  myocardium at animals with EIED, combinations  
of statins and L-norvalin (M±m; n=10) 
Groups  
of animals 
 
Indicators 
Units of measure 
1 2 3 4 
Intact EIED 
EIED +  
rosuvastatin + L-
norvalin 
EIED +  
symvastatin + L-
norvalin 
Without 
functional 
trials 
LVP mm of mercury 105,3±4,5 110,1±7,1 105,3±3,8 110,9±4,3 
+dp/dtmax mm of mercury per sec  6570,9±783,4 8838,9±340,7
*1
 6262,2±552,7*2 5714,6±603,9*2 
-dp/dtmax mm of mercury per sec  4142,1±452,6 5206,1±255,7
*1
 3824,5±381,4*2 4016,9±361,0*2 
CCR hart bits per second 361,3±14,7 372,5±10,5 375,4±7,0 393,5±5,3*1-3 
IFS mm of mercury х hart bits per sec 38421,1±2849,6 40756,4±2279,9 39500±1557 43716±2050*1-3 
Test on 
adrenoreacti
vity  
LVP mm of mercury 201,5±9,4 240,3±8,7*1 200,1±9,9*2 210,1±5,2*2 
+dp/dtmax mm of mercury per sec  10997,8±777,6 13959,2±735,9
*1
 10770,0±401,6*2 11646,8±700,9*2 
-dp/dtmax mm of mercury per sec  5697,1±650,8 7830,5±520,9
*1
 6051,7±345,8*1,2 6456,2±434,5*1,2 
CCR hart bits per second 374,4±14,5 379,0±9,4 376,4±8,3 379,9±9,4 
IFS mm of mercury х hart bits per sec 76236,2±5813,7 91294,1±4546,3*1 75000±3416,0*2 79884±2947,0*2 
Test with 
compression 
of aorta 5 
sec. 
LVP mm of mercury 233,2±9,9 220,2±6,5 217,5±6,8 219,4±11,1 
+dp/dtmax mm of mercury per sec  9227,3±459,3 9555,9±400,2 7153,0±688,3
*1,2
 7890,1±780,7*1,2 
-dp/dtmax mm of mercury per sec  3674,7±207,5 4241,6±275,4
*1
 3708,8±215,2*2 3949,0±488,4*2 
CCR hart bits per second 284,9±21,7 366,8±10,6*1 315,0±11,4*2 320,0±16,7*2 
IFS mm of mercury х hart bits per sec 65459,1±3968,0 80568,6±2804,2*1 68806±3781,0*2 70116±5322,0*2 
Test with 
compression 
of aorta 25 
sec. 
LVP mm of mercury 212,7±10,9 179,4±3,9*1 202,8±7,2*2 200,0±8,7*2 
+dp/dtmax mm of mercury per sec  6826,7±458,6 5144,0±238,3
*1
 6534,3±347,8*2 6639,1±529,4*2 
-dp/dtmax mm of mercury per sec  3210,5±261,5 3034,3±237,6 3146,8±230,4 3425,4±344,4 
CCR hart bits per second 306,8±36,1 259,4±14,4*1 309,4±10,6*2 279,1±21,5*2 
IFS mm of mercury х hart bits per sec 63004,9±5858,3 46520,4±2687,8*1 62196±1577,0*2 56322±5373,0*2 
Reoxygeneti
on test 
LVP mm of mercury 194,9±9,5 228,5±10,2*1 196,5±5,2*2 213,7±7,2*2 
+dp/dtmax mm of mercury per sec  8488,0±698,1 12221,3±363,4
*1
 9150,5±383,3*1,2 9937,2±500,6*1,2 
-dp/dtmax mm of mercury per sec  4490,0±320,7 4692,5±219,5 5047,6±496,1 4550,6±390,7 
CCR hart bits per second 252,3±19,3 269,6±14,9 286,7±16,3 276,1±20,1 
IFS mm of mercury х hart bits per sec 49670,1±4750,2 62068,7±5006,4*1 56149±3179*1,2 58749±4200*1,2 
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When carrying out test with a reoxygenetion 
on animals was normalized with EIED against 
application of L-norvalin and rozuvastatin or 
simvastatin LVP, indicators of +dp/dtmax and IFS 
decreased, but not to control values. reliable changes 
- dp/dtmax and CCR didn't take place (table 5). 
In group of animals from EIED receiving a 
combination of L-norvalin and simvastatin GAA was 
normalized, the level of MDA and AGP decreased, 
the activity of catalase corrected and the maintenance 
of SMNO increased. L-norvaline  combination with 
rozuvastatin normalized MDAL, activity of catalase, 
reduced the AGP level and increased concentration of 
SMNO, GAA (figure 2). 
 
 
Designations: circle radius – indicators of intact animals;  
- indicators of rats with EIED; 
- indicators of rats with EIED, receiving symvastatin + L-norvalin;  
 indicators of rats with EIED, receiving rozuvastatin + L-norvalin; 
- normalized indicators. 
Figure 2.  Change of oxidatic indicators and level of stable metabolites of nitrogen oxide on rats with EIED against the 
combined application of statins and LL-norvalin 
As a matter of record it is possible to claim that 
L-norvalin combinations to statines were more 
effective, than separate application of preparations in 
correction of functional activity of endothelium and 
myocardium, metabolic indicators of animals with 
EIED. At the same time the combination of L-
norvalin and a rozuvastatin was more effective. 
The estimated mechanism of development of 
endothelial dysfunction at inflammatory process 
which has made a work basis, following: the 
monocytes activated under the influence of bacterial 
endotoxin migrate in a subendotelialny layer, allocate 
cytokine, active radicals of oxygen, activate 
endoteliocite which in turn allocate adhesive 
molecules, hem attractant (attract neutrophils and 
monocytes in the inflammation center), cytokine. All 
these processes in total strengthen processes of an 
inflammation, aggregation of blood cells, violation of 
processes of microcirculation. Besides, there is an 
activation the process of peroxidation which products 
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damage endoteliotcite. In this situation synthesized 
L-arginin NO at interaction with active radicals of 
oxygen is left on education by peroxynitrite of the ion 
possessing most expressed cytotoxic activity. 
Besides, the peroxidation, active radicals of oxygen, 
cause oxidation of lipoprotein of lower density which 
together with peroxide products are taken fabric 
macrophages, are transformed to foamy cages that 
causes remodeling of vessels. At the 
macromorphological level the vazokonstriktion, 
microthrombosis in internals (kidneys, a liver, heart) 
is result of such pathogenetic mechanisms, as 
becomes the main reason for a lethal outcome at 
EIED [20, 21]. 
NO which is formed during activation of 
enzymatic systems of endoteliotsite in the conditions 
of infectious process contacts radicals of oxygen, 
forming the peroxynitrites aggravating a current of 
septic shock and ischemia of bodies as this 
connection suppresses work of a cycle of Krebs and 
activity of a ribonukleotidreduktaza inhibits 
formation of energy in mitochondrions. In turn, 
bacterial endotoxin intensifies synthesis of the major 
proapoptotichesky factor – a squirrel r53, figuratively 
called «the guard of a genome». On the other hand, 
the induction of eNOS under the influence causes in 
the endothelial cages morphological and biochemical 
changes, typical for apoptosis, at the same time 
dependence of activity of apoptosis on concentration 
radical superoxide of oxygen and nitrogen oxide is 
proved. The balanced proportion of these substances 
in a cage which is an important factor of regulation of 
apoptosis possesses the most expressed 
antiapoptotichesky action [22].  
Estimated points of application of preparations 
in the development mechanism sepsis - the induced 
endothelial dysfunction the following: statins possess 
the expressed anti-inflammatory activity, thereby 
modulate activity of macrophages, endoteliocite, 
reduce aggregation of blood cells, concentration of a 
substratum for processes the peroxidation, thus under 
the influence of statin expressiveness of 
inflammatory reaction in a wall of vessels decreases, 
functional activity of macrophages, endothelium is 
normalized. L-norvalin, in turn, blocks the arginaza 
turning L-arginin in ornitin that is provides increase 
of concentration of a substratum (L-arginin) for a  
NO, and, as a result, raises effective concentration. 
At the expense of it there is a vazodilatation and 
microcirculation in internals improves [23, 24]. 
Similar results were obtained on a similar model 
using statins meldonium and selective inhibitor of 
arginase 2 [25, 26, 27]. 
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